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Purpose: To compare the clinical outcome and complica-
tions following total knee arthroplasty (TKA) in diabetic and
non-diabetic patients, and to identify diabetes-related risk
factors for negative outcomes. Materials and Methods: 222
primary TKAs in patients with diabetes were evaluated using
Knee Society scores and Hospital for Special Surgery score.
Postoperative complications were reviewed retrospectively.
The mean follow-up was 53.2 months. The effect of diabetes-
related factors and comparison with a matched control group
were analyzed statistically. Results: Significant improvements
were noted in all the scores after TKA (p < 0.05). There was
no statistical difference in clinical sores between the diabetic
and non-diabetic patients. In multivariate analysis associating
age, gender and body mass index with pain and knee score
at the latest follow-up, the average knee scores in normal and
overweight group were found to be significantly higher than
those in the obese group. The diabetic patients had an
increased overall incidence of postoperative complications
(17.6%) compared with the control group (8.1%) (p < 0.05).
Particularly, the rate of wound complications such as skin
necrosis, bulla formation or erythema with drainage was
higher in the diabetic group (p < 0.05). Diabetes-related factors
did not influence the incidence of complications. Associated
diseases were the only significant risk factors correlated with
wound complications and meniscal bearing dislodgement.
Conclusion: Patients with diabetes can benefit from TKA,
even though diabetic patients are at an increased risk for
overall postoperative and wound complications. Preoperative
factors such as obesity and associated diseases may adversely
affect the clinical outcome of TKA in diabetic patients.
Key Words: Diabetes mellitus, total knee arthroplasty, clinical
outcome, complication, risk factor
INTRODUCTION
The prevalence of diabetes is rising as the
elderly population increases. In Koreans, the age-
adjusted prevalence of diabetes is 7.6%, cor-
responding to 2.7 million with diabetes. The
prevalence of diabetes increases with age and
reaches its peak in the oldest age-group; in
population of 60 - 69 years of age the prevalence
of diabetes is about 20%.
1
Diabetes has been known to adversely affect the
musculoskeletal system, to delay collagen syn-
thesis,
2,3 and to impair wound healing
4 and
phagocytosis.
5 These factors may lead to higher
risks of various infections and poorer wound
healing after any surgical procedure. Some studies
have shown an altered bone and mineral
metabolism in diabetic animals and humans,
6-10
and the fracture healing process may be delayed
by this condition.
11-14 Theoretically, these effects
could contribute to prosthesis loosening in total
joint replacement.
Total knee arthroplasty (TKA) is one of the
most frequently performed orthopaedic opera-
tions in the elderly population. As TKA in
diabetic patients has become more common, it has
received increasing attention. Some authors have
reported an increased rate of deep infection in
diabetic patients,
15-18 while others have raised
concerns over wound complications.
16-19
The aim of our present study was to compare
the clinical outcome and complications following
TKA in a consecutive series of diabetic and non-
diabetic patients, and to identify diabetes-related
risk factors for negative outcomes.
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MATERIALS AND METHODS
Patient characteristics
Between 1995 and 2004, 1581 primary TKA
procedures were performed at our institution.
Surgery was performed by one senior author. In
this consecutive series, 222 primary TKAs (14%) in
171 patients with diabetes were available with a
minimum follow-up period of 2 years. Only
patients with osteoarthritis were included in the
current study. The medical records of these
patients were reviewed in detail to assess the
demographic and medical features of each patient
(Table 1). The study included 155 women (203
TKAs) and 16 men (19 TKAs) with a mean age of
67.6 years (range, 50 - 86 years) at the time of
operation. Fifty-one patients had bilateral staged
TKA. The mean duration of follow-up was 53.2
months (range, 24 - 132 months). Nine patients
(5.3%) had previous knee procedures before de-
finitive TKA; 5 received arthroscopic debridement,
1 high tibial osteotomy and 3 open reduction and
internal fixation for distal femur or proximal tibial
fracture. To identify diabetes-related factors that
affect the outcome after TKA, several diabetes
associated variables were investigated, including
duration of diabetes, the number of major
systemic complications of diabetes, body mass
index (BMI) and glycosylated hemoglobin values
(HbA1c). Twenty-four patients (31 knees; 14%)
were treated with insulin, and 147 patients (191
knees; 86%) were treated with oral hypogly-
cemics. The mean time from the onset of diabetes
to the time of surgery was 7.6 years (range, 1 - 30
years). Twenty-nine patients (37 knees; 17%) had
major systemic complications of diabetes at the
time of surgery. Twenty-five patients (32 knees)
had one complication, and four patients (5 knees)
had two complications. The distribution of com-
plications from diabetes is listed in Table 2. Table
3 shows associations with various diseases; the
most common was hypertension associated with
148 knees (66.7%). Body mass index (BMI) is the
ratio of weight to height, calculated by dividing
the weight by the square of the height (kg/m
2).
Patients were divided into three categories based
on their BMI: individuals with a BMI of 20 - 25
Table 1. Demographic Data
Gender (No. of patients, %)
Male 16 (9.4%)
Female 155 (90.6%)
Age (mean, range) 67.6 yrs (50 - 86)
Follow-up period (mean, range) 53 months (24 - 132)
Type of treatment (No. of patients, %)  
Insulin 24 (14%)
Oral hypoglycemics 147 (86%)
Duration of diabetes (mean, range) 7.6 yrs (1 - 30)
Number of complications of diabetes (No. of patients)  
0 142
1 25
2 4
Body mass index (BMI) (mean, range) 26.5 kg/m
2 (18.9 - 36.9)
Normal 74 knees (33.3%)
Overweight 119 knees (53.6%)
Obese 29 knees (13.1%)
Glycosylated hemoglobin value (HbA1c) (mean, range) 7.5% (4.4 - 12.2)
Previous knee surgery (No. of knees)  
Arthroscopic debridement 5
High tibial osteotomy 1
Open reduction and internal fixation 3Risk Factors for TKA in Diabetes
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are considered normal weight; 25 - 30 overweight;
and > 30 obese.
20-22 In the present study, the mean
BMI was 26.5 kg/m
2 (range, 18.9 - 36.9). Seventy-
four knees (33.3%) were associated with normal
weight, 119 knees (53.6%) with overweight and 29
knees (13.1%) with obese. HbA1c is a useful index
of blood glucose control over a period of 4 - 5
weeks.
23-25 HbA1c values, taken within 1 month
before TKA to evaluate diabetes, were available
for 185 knees with a mean HbA1c of 7.51% (range,
4.40 - 12.20). Antibiotic prophylaxis and a tour-
niquet were used in all patients. Prophylaxis for
thromboembolism was not performed. All knees
were approached through a standard medial
parapatellar incision, and all patients received
cefuroxime-impregnated cement (1 g of cefuroxime
in 40 g of CMW) with mobile bearing low contact
stress total knee system (Depuy, Warsaw, IN,
USA). Full weight bearing ambulation and range
of motion exercises were started on the first
postoperative day.
Clinical evaluation
All the patients were identified only by the
sequential number of TKA while administering
rating scores and complications to stay blind to
the patient’s status as either a diabetes or control
subjects. Patients were preoperatively evaluated
according to the Knee Society clinical scoring
system and then postoperatively at 6 weeks, 6
months, 1 year, and yearly thereafter.
26 Values for
knee and function score were obtained to assess
prosthetic knee and patient function separately.
Pain score was also obtained from the knee scores
comprising pain, range of motion and stability.
Ratings of 90 - 100 were considered excellent, 80 -
89 good, 70 - 79 fair, and less than 70 poor. We
also evaluated Hospital for Special Surgery (HSS)
knee-rating scores.
27 Knees with a rating of 85 or
more were designated as excellent, 70 - 84 good,
60 - 69 fair, and less than 60 poor. Perioperative
and postoperative complications were noted
retrospectively for all patients. Complications in-
cluded wound complications, superficial or deep
infection, meniscal bearing dislodgement, peri-
prosthetic fracture, deep vein thrombosis (DVT),
peroneal nerve palsy and other medical compli-
cations. Wound complications were defined as
marginal skin necrosis, bulla formation or wound
erythema with drainage that persisted longer than
usual. To avoid observational bias, only the cases
were determined to be adopted of which hospital
stay was prolonged at least two days or more for
wound management or additional use of
intravenous antibiotics. Patients were clinically
screened for DVT and it was confirmed with
Doppler ultrasonography when diagnosis was
suspicious.
Control group
To compare the outcome after TKA in diabetic
patients with that of non-diabetic patients, a
randomized matching with controls was done
from the same series using computer generated
matching process. Non-diabetic patients were
matched one to one with diabetic patients, based
on the following criteria:
17,19 (1) age at surgery
(within 5 years), (2) gender, (3) diagnosis of
arthritis, (4) length of follow-up period (within 1
year), (5) implant design, and (6) BMI (same BMI
category). Characteristics of the control and
diabetic groups are compared in Table 4. There
were no statistical differences in any of the
Table 3. Associated Diseases
Diseases No. of knees (%)
Hypertension 148 (66.7)
Hypothyroidism 1 (0.5)
Parkinsonism 2 (0.9)
Congestive heart failure 4 (1.8)
Cushing syndrome 10 (4.5)
Nephrotic syndrome 1 (0.5)
Liver cirrhosis 1 (0.5)
Table 2. Preoperative Systemic Complications Associated
with Diabetes Mellitus
Complications No. of patients (%)
Coronary arterial occlusive disease 10 (5.8)
Peripheral arterial occlusive disease 3 (1.8)
Cerebrovascular accident 5 (2.9)
DM neuropathy 6 (3.5)
DM retinopathy 4 (2.3)
DM nephropathy 5 (2.9)Table 5. Average Knee Society Scores
Score Diabetic status Preoperative Last follow-up
Knee Yes 50 ± 16 92 ± 12
No 52 ± 17 92 ± 10
Pain Yes 22 ± 10 45 ± 9
No 23 ± 10 45 ± 8
Function Yes 47 ± 14 74 ± 20
No 50 ± 13 74 ± 20
Table 6. Average Hospital for Special Surgery Scores
Diabetic status Preoperative Last follow-up
Yes 66 ± 10 89 ± 10
No 66 ± 11 89 ± 9
Hong Kyo Moon, et al.
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matching criteria between the two groups.
Statistical assessment
Univariate analyses were performed to idenfity
significant preoperative factors of the measured
outcome. P values less than 0.05 were considered
significant. The paired t-test was performed to
determine whether there was a significant impro-
vement in the clinical scores after TKA. Clinical
scores were compared with those of the control
group using the Student's t-test. Overall and
individual complication rates were compared
with the chi-square test. The relationship between
clinical scores and continuous variables, such as
duration of diabetes, BMI and the value of
HbA1c, were analyzed using the Pearson
correlation coefficients test. In addition, analysis
of variance (ANOVA) was used when the com-
parison was performed with respect to BMI
subgroups. However, in a number of major
systemic complications of diabetes, the samples
of group "2" did not fulfill the normality test,
therefore, they were correlated with the clinical
scores using the Kruskal-Wallis test as a
nonparametric test. The chi-square test was used
to analyze the effect of diabetes-related factors on
complication rates.
Once possibly significant predictors of outcome
had been identified by this method, multivariate
analysis was carried out to identify any
predictors that would independently alter
outcome. Computation was performed with the
Statistical Analysis System (SAS Institute, Cary,
North Carolina, USA).
RESULTS
Clinical results
In the diabetic group, the average preoperative
Knee Society knee score was 50 ± 16, and the
average pain and function scores were 22 ± 10 and
47 ± 14, respectively. There was a significant
improvement in all the scores (p < 0.0001) after
TKA. At the latest follow-up, knee, pain, and
function scores had increased to 92 ± 12, 45 ± 9
and 74 ± 20, respectively (Table 5). There was also
improvement in the HSS score from 66 ± 10 to 89
± 10 (p < 0.0001) (Table 6). The control group also
showed a significant improvement in the Knee
Society scores and HSS score (Tables 5 and 6). At
the latest follow-up examination, there was no
pain in 112 knees (50.5%), mild pain in 102
(45.9%), moderate pain in 6 (2.7%) and severe pain
in 2 (0.9%). One hundred and seventy seven
(79.7%) knees were rated excellent, 21 (9.5%)
good, 16 (7.2%) fair, and 8 (3.6%) poor according
to the Knee Society rating scale.
There were no statistically significant differ-
ences in the average preoperative Knee Society
knee, pain and function scores between the
diabetic and control groups (p > 0.05). Likewise,
there were no statistical differences in the average
postoperative knee, pain, and function scores
between the two groups (Table 5). There were no
significant differences in the average preoperative
Table 4. Comparison of Diabetic and Control Groups
  Diabetic Control
Age (yrs) 67.6 67.4
Gender (No. of patients)    
Male 16 16
Female 155 155
Diagnosis OA (100%) OA (100%)
Follow-up period (months) 53.2 54.4
Body mass index (kg/m
2) 26.5 25.9
OA, osteoarthritis.Risk Factors for TKA in Diabetes
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and postoperative HSS score between the two
groups (Table 6).
Univariate analysis suggested that age, gender
and BMI might affect the clinical outcomes. A
significant relationship between other predictors
and clinical outcomes could not be detected (p >
0.05). However, associated diseases and the number
of diabetic complications were related with pre-
operative pain scores. For the number of diabetic
complications, the median value was 10 for group
2, 20 for group 1, and 30 for group 0 (p = 0.0035),
and 30 in patients without associated diseases, 20
with hypertension, 20 with congestive heart failure,
and 15 with Cushing syndrome (p = 0.0096).
Dividing the BMI into 3 subgroups, the mean
postoperative pain score was 44 ± 6 in the normal
weight group, 46 ± 7 in the overweight group, and
41 ± 14 in the obese group (p = 0.0182). The mean
postoperative knee score was 92 ± 10 in the normal
weight group, 94 ± 8 in overweight group, and 86
± 24 in obese group (p = 0.0109). Multivariate
analysis associating age, gender and BMI with the
pain and knee score at the latest follow-up was
performed. Once the analysis was carried out, the
differences in the knee scores were all significant,
whereas only the difference in the pain score was
significant between the overweight and obese
groups.
Postoperative complications
The diabetic group had an increased overall
incidence of postoperative complications com-
pared with the matched control group (17.6% vs.
8.1%; p = 0.0029). The rate of wound complications
was significantly higher in patients with diabetes
than in patients without diabetes (9.5% vs. 5.0%;
p = 0.0461). The rate of dislodgement was 2.7% in
diabetic versus 0.5% in non-diabetics and was
found to be not significantly different (p = 0.0585).
The rates of other complications were not statisti-
cally different (Table 7). Peroneal nerve palsy,
serious medical complications and medial
instability were not observed in the control group.
Six meniscal bearing dislodgements occurred
postoperatively at an average of 18.8 months
(range, 2 - 48) and were treated with meniscal
bearing exchange. One each superficial wound
infection occurred in the both groups, and they
were treated with debridement of the wound and
intravenous antibiotics. Two deep infections
(0.9%) occurred in the diabetic group, whereas
one deep infection (0.5%) in the control group.
The deep infections in the diabetic group occurred
11 weeks and 33 months postoperatively, and the
causative microorganisms were methicillin-resistant
coagulase negative streptococcus and Escherichia
coli, respectively. The deep infection in the control
group occurred 36 months postoperatively, and
the causative organism was Acinetobacter baumannii.
These infections were treated with debridement of
the joint and intravenous antibiotics, and the
infected implants were retrieved and replaced
with an antibiotic impregnated cement spacer.
Definitive revisional total knee arthroplasty was
performed 6 months later. Clinical features of the
diabetic patients with deep infection are listed in
Table 8. The patients were diagnosed as diabetes
Table 7. Postoperative Complications
Complication Diabetic knees (%) Control knees (%) p value
Wound complication 21 (9.5) 11 (5.0) < 0.05
Meniscal bearing dislodgement 6 (2.7) 1 (0.5) ns
Superficial wound infection 1 (0.5) 1 (0.5) ns
Deep joint infection 2 (0.9) 1 (0.5) ns
Periprosthetic fracture 1 (0.5) 1 (0.5) ns
Deep vein thrombosis 2 (0.9) 3 (1.4) ns
Peroneal nerve palsy 1 (0.5) 0 (0) ns
Medical complication 3 (1.4) 0 (0) ns
Medial instability 2 (0.9) 0 (0) ns
Overall 39 (17.6) 18 (8.1) < 0.05
ns, not significant.Hong Kyo Moon, et al.
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one year before surgery and had no complication
of diabetes preoperatively. One diabetic patient
with peroneal nerve palsy underwent electrical
stimulation therapy and showed recovery of ankle
dorsiflexion 3 weeks postoperatively and big toe
extension one year postoperatively. There were no
perioperative mortalities in our series.
DISCUSSION
A few studies evaluated the effect of diabetes
on outcome following TKA. Serna et al. investi-
gated the effect of various diagnosis, the use of
cement versus cementless fixation, preoperative
deformity, the number of prior surgeries, patient
weight greater than 80 kg, and Chanley functional
class, and suggested the necessity to examine the
degree of glucose control in terms of its effect on
the final outcome. To our best knowledge, the cur-
rent study is the first attempt to examine the effect
of diabetes-related factors (duration of diabetes,
number of complications of diabetes, body mass
index, HbA1c value, type of treatment of diabetes,
dose of insulin) on the clinical ratings and the
incidence of postoperative complications rates.
In the present study, there was a significant
improvement in HSS and Knee Society scores
between preoperative and postoperative values
for both control and diabetic groups, and these
improvements of the scores were associated with
pain relief and reflected changes in walking
distance and gait aids. In diabetic patients,
sensory and autonomic neuropathy can exist at
subclinical levels,
28 and the resulting loss of pain
perception may contribute to higher Knee Society
knee and pain scores in patients with diabetes. In
addition, combined chronic complications of
diabetes and medical comorbidities may have an
adverse effect on the function and mobility of
patients. These ideas are supported by Meding et
al.,
29 who reported higher knee and pain scores
and lower function scores in patients with
diabetes. Papagelopoulos et al.
19 also reported
lower function scores in diabetic patients; whereas
the Knee Society knee score and HSS scores were
lower in patients with diabetes in their series.
Likewise, Serna et al.
17 reported lower HSS scores
in patients with diabetes. Those authors recognized
that diabetes might influence clinical outcome.
However, the influence of diabetes-related factors
on clinical outcome was not addressed in their
study. We demonstrated that there was no dif-
ference in clinical scores between the diabetic and
non-diabetic patients, and univariate analysis
revealed that BMI was the single significant
diabetes-related predictor on clinical outcome. It
appears, therefore, that the lower knee score in
the obese group is largely due to the lower pain
score. Low postoperative pain scores have been
attributed to the increased rates of postoperative
patellofemoral symptoms among obese patients.
30-32 There have been a number of reports on the
outcomes of TKA among obese patients, and there
is a general consensus that obese patients have
satisfactory clinical and radiological results in the
long-term.
32-34 Adverse outcomes have been
reported in highly or morbidly obese patients,
34,35
however the current study did not include
morbidly obese patients and involved only one
patient with a BMI greater than 35 kg/m
2. This
may explain the lack of difference in postopera-
Table 8. Clinical Features of Diabetic Patients with Deep Infection
  Patient 1 Patient 2
Type of treatment Oral hypoglycemics Oral hypoglycemics
Duration of diabetes 1 yr 1 yr
Complication of diabetes None None
BMI (kg/m
2) 28.6 23.4
HbA1c (%) 7.4 -
Associated disease Hypothyroidism Hypertension
Previous surgery None O/R and I/F
O/R, open reduction; I/F, internal fixation.Risk Factors for TKA in Diabetes
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tive complication rates between the subgroups of
BMI in the current study.
There was higher overall postoperative compli-
cation rate in diabetic patients, but all the in-
dividual complication rates were not statistically
different. The most common complications were
wound complications (9.5%) and meniscal bearing
dislodgement (2.7%). Wound complications after
TKA in diabetic patients has been described by
several authors;
15-19 however, the definitions of
wound complications are somewhat different in
each study. Meding et al. defined it as skin necrosis,
superficial infection, and wound dehiscence, while
Papagelopoulos et al. defined it as wound
dehiscence, hematoma, and wound discharge.
Other groups defined wound complications as
superficial infection.
16-18 Furthermore, the published
rate of wound complications varies from 1.2% to
12%. The rate observed in the current study (9.5%)
is not directly comparable with other studies,
because it represents marginal skin necrosis, bulla
formation, or wound erythema with drainage that
persisted longer than usual. There were 14 cases
of erythema, 5 cases of necrosis, and 2 cases of
bulla formation. No wound dehiscence was
observed. These are minor complications compared
with those reported by other authors, and none of
them caused significant morbidity.
The incidence of meniscal bearing dislodgement
has been reported to vary from 0.83% to 9.3%.
36,37
The current study revealed a dislodgement rate of
2.7%. Joint sepsis has been a matter of concern
after TKA in diabetic patients. England et al.
16
reported a deep infection rate of 7% and a wound
complication rate of 12% in diabetic patients after
TKA. In that series, the rate of deep joint infection
in diabetic patients was 10 times higher than the
reported incidence of sepsis in non-diabetic
patients, therefore they suggested the use of anti-
biotic-impregnated cement. Chiu et al.
15 performed
a prospective randomized study to evaluate the
role of cefuroxime-impregnated cement in the
prevention of deep infection at primary TKA in
patients with diabetes. They found no cases of
deep infection in the group with cefuroxime-
impregnated cement compared with a deep
infection rate of 13.5% in the control group, and
concluded that cefuroxime-impregnated cement
was effective in the prevention of deep infection
in patients with diabetes and suggested routine
addition of cefuroxime. Its thermal stability and
biological effectiveness in cement as well as good
clinical result have been well documented, there-
fore we have routinely been using cefuroxime-
impregnated cement for primary TKA, vindicating
the idea that prophylactic use of antibiotic bone
cement should be the standard of practice for
primary TKA.
38 Meding et al. also added cefuroxime
to cement and reported a deep infection rate of
1.2% in diabetic patients and 0.7% in nondiabetic
patients, which are comparable with ours. In their
study, all deep infections occurred in patients
with insulin-dependent diabetes, whereas all deep
infections in the current study occurred in patients
who were treated with oral hypoglycemics (Table
8). Therefore, diabetes-related factors appear to
have little influence on the rate of deep infection.
A higher than expected aseptic loosening rate in
Table 9. Statistical Analysis of the Relationships between Preoperative Factors and Postoperative Complications
  Cx 1* Cx 2
Duration of diabetes 0.8307 0.4052
No. of complications of diabetes 0.4737 1.0000
Body mass index 0.1023 0.3069
HbA1c value 0.4078 0.1921
Type of treatment of diabetes 0.1778 0.5625
Dose of insulin 0.4180 -
Previous surgery 0.4106 1.0000
Associated diseases 0.0014* 0.0195*
*wound complications.
meniscal bearing dislodgement.
the statistical analysis was done with Student's t-test for dose of insulin, chi-square test for others.Hong Kyo Moon, et al.
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patients with diabetes has been reported by
several authors.
19,29 With a mean follow-up period
of 4.3 years, Meding et al. demonstrated that the
rate of aseptic loosening was significantly higher
in patient with diabetes (3.6%) than with non-
diabetic patients (0.4%). After a mean follow-up of
8 years, Papagelopoulos et al. reported the aseptic
loosening rate of 7.4%, which was higher than the
control group. However, there are also various
studies showing contradictory outcomes. With the
mean follow-up of 4.2 years. Chiu et al.
15 reported
no aseptic loosening, whereas others
16-18 have
reported the rate of aseptic loosening, ranging
from 2 to 3% with the mean follow-up from 3.6
to 4.5 years, however only 1 or 2 aseptic
loosenings were included in the series. Similarly,
there was no aseptic loosening after a mean
follow-up of 4.4 years in our series. After all,
diabetes theoretically could contribute to implant
loosening, nevertheless, reported incidences are
not consistent: There seem to be other factors such
as demographic differences besides diabetes in
developing aseptic loosening.
The current study represents a retrospective
review of clinical outcomes and postoperative
complications in diabetes following TKA. While
BMI standards reported by WHO expert com-
mittee were used in this study, several authors
have raised a concern for its inability to detect
differences and account for changes by age,
gender,
39 and ethnic group.
40-43 However, the pur-
pose of those studies were to precisely estimate
the true association between adiposity and disease
risk. Judging from the fact that the outcomes after
TKA are affected by mechanical aspect rather than
the possibility of cardiovascular disease, we think
that it is a logical way to make BMI standard as
an international classification to compare with
existing studies.
Univariate analysis to identify a significant
predictor of postoperative complications was pos-
sible only for wound complications and meniscal
bearing dislodgement, because the number of
patients with other complications was too small.
As listed in Table 9, preoperative factors asso-
ciated with diabetes did not affect the rate of
wound complication and meniscal bearing dis-
lodgement. The only significant preoperative
factor affecting the complication rates was
associated disease. Patients who had iatrogenic
Cushing syndrome before TKA had an odds ratio
of 19 for wound complications and 38 for meniscal
bearing dislodgement compared with patients
without associated disease, and power analysis
showed a power of 0.95 and 0.80, respectively,
validating the ratios.
In conclusion, our present results indicate that
patients with diabetes have preoperative clinical
conditions similar to non-diabetic patients and
benefit equally well from TKA. However, the
diabetic patients were at an increased risk for
overall postoperative complications and wound
complications. Preoperative factors such as BMI
and associated diseases may adversely affect the
clinical outcome of TKA in diabetic patients.
Therefore, it is necessary to balance the benefits of
TKA against the risks and exercise extra caution
in patient selection.
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